Cell Therapy Training Course 2017- Seattle
Share |
 
 

Thanks to all who attended the Second ISCT-ASBMT Cell Therapy Training Course!

 

Summary  Program Testimonials Scholars


Summary

The second biennial Cell Therapy Training Course (CTTC), jointly held with ASBMT from Oct 23-27, 2017, was a rousing success. The course spanned a week of intensive teaching, collaboration, and networking amongst the Scholars and Faculty. Covering the full spectrum of the Cellular Therapy field, the CTTC seeks to expose Scholars to those topics that may not have been part of their formal education. As space is limited in the CTTC, and fully funded by ISCT, ASBMT and our generous Industry sponsors, there is an intense competition for the limited number of Scholar opportunities. Thirteen International Scholars, representing five countries, were selected for the CTTC, based on their experience and the strength of their project proposal. We believe that these Scholars represent the future of our field and that the investment in their training will provide dividends throughout their careers. As part of the CTTC, Scholars have access to ISCT and ASBMT Leadership, allowing for interactions that may not otherwise be possible in the limited scope of a Conference or Seminar speaker. Congratulations to the 2017 CTTC Scholars! 

ProgramClick here

Testimonials 

As a clinical researcher, I had the chance to learn a lot about what goes on behind the curtains. This course has strengthened my understanding of the next generation cellular therapy.”
Monzr Al Malki, USA

 

 

 Co-Chairs John Barrett, MD and David DiGiusto, PhD with the Scholars of the CTTC.

I came away from this course excited for the future of cell therapy and with a much clearer idea of the way forward for my particular clinical trial proposal.

This was absolutely one of the best courses I have attended. The opportunity to spend a week with faculty who stepped out of the pages of literature to discuss my ideas on cell therapy was a phenomenal privilege. It was extremely well-run and the faculty and my fellow scholars were a wonderful group of people, several of whom I have been in contact with since the course. I am truly grateful to have been selected and cannot recommend this course highly enough to anyone who is starting out in the field of cell therapy.” 
– Melanie Grant, USA

 

Bruce Levine, PhD, Chair of the ISCT Immuno and Gene Therapy Committee discusses T-cell biology with the Scholars

The 2017 Cell Therapy Training Course exceeded my expectations in terms of the course content and the extensive knowledge shared with us by the faculty based on their years of successful experience in complex cell therapy research and actual clinical practice. It was also very enlightening to meet with developing cell therapy researchers like myself with whom I now have established professional relationships in the US, Australia, France and the Netherlands!
 – Folashade Otegbeye, USA

 

Co-Chairs John Barrett, MD and David DiGiusto, PhD surrounded by the Scholars and Faculty
of the CTTC.

“From my side, after having seriously worked on a project proposal in fulfillment of the requirements for the course, I had high expectations on ameliorating the project. This was indeed the beginning, since I was introduced to several aspects of cell therapy I had not deeply reflected on beforehand. The course gave me insight into regulatory, quality systems, practical manufacturing issues, clinical trial design/statistics issues, proper documentation, release testing/product characterization, … I did not realize how multi-disciplinary the approach needs to be, even at early preclinical development stages. The faculty administering the course had deep practical insight and openness to relay their knowledge and experience; qualities I continue to admire in such pioneers in the field. Furthermore, the practical aspects of the course, visiting production facilities and Nohla Therapeutics rounds up the circle in such an education.” 
 Bechara Mfarrej, France

 

 2017 Scholars

International Scholars

Bechara Mfarrej, MS
Research and Development
Institut Paoli-Calmettes
Marseilles, France

Anton Terwisscha van Scheltinga, PhD
Head of Translational Drug Discovery and Development
Leiden University
Leiden, Netherlands

Charan Thej, MS
PhD Student
Manipal University
Bangalore, India

Carrie van der Weyden, MBBS
Haematology Fellow
Peter MacCallum Cancer Center
Victoria, Australia

Zlatibor Velickovic, PhD
Production Manager
Royal Prince Alfred Hospital
Sydney, Australia

Karin Wisskirchen, PhD
Postdoctoral Researcher
Technical University of Munich
Munich, Germany

 

North American Scholars

Monzr Al Malki, MD
Assistant Professor
City of Hope National Medical Center
Duarte, CA, United States

Felipe Bedoya, MD, PhD
Instructor of Medicine
Harvard Medical School
Charlestown, MA, United Stated

Mark DeWitt, PhD
Project Scientist
University of California
Berkeley, CA, United States

Melanie Grant, PhD
Research Postdoctoral Fellow
Children's National Medical Center
Washington, DC, United States
Folashade Otegbeye, MBChB, MPH
Clinical Instructor
University Hospitals Cleveland Medical Center
Cleveland, OH, United States
Daniel Dever, PhD
Instructor
Stanford University
Stanford, CA, United States

 

Host Institution Scholars

Elizabeth Krakow, MD, CM, MSc
Assistant Member
Fred Hutchinson Cancer Research Center
Seattle, WA, United States
Corinne Summers, MD
Acting Instructor
University of Washington
Seattle, WA, United States

 

Co-Chairs

David DiGiusto,PhD
Executive Director
Stem Cell and Cellular Therapeutics Operations
Stanford Healthcare
Stanford, CA, USA
John Barrett, MD
Chief
Stem Cell Allotransplantation Section
Hematology Branch
National Heart, Lung and Blood Institute
Bethesda, MD, USA

 

Faculty Planning Committee

Shelly Heimfeld, PhD
Director
SCCA Cellular Therapy Laboratory
Member, Fred Hutchinson Cancer Research Center
Seattle, WA, USA

Helen Heslop, MD, DSc (Hon)
Professor of Medicine and Pediatrics
Interim Director, Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX, USA

Colleen Delaney, MD, MSc
Chief Medical Officer
Nohla Therapeutics
Associate Member, Fred Hutchinson Cancer Research Center
Associate Professor, University of Washington
Seattle, WA, USA

Lizabeth Cardwell, MT(ASCP), MBA, RAC
Principal Consultant
Compliance Consulting
Seattle, WA, USA 


© 2018 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered service marks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.